These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 8635868

  • 1. Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance.
    Futscher BW, Foley NE, Gleason-Guzman MC, Meltzer PS, Sullivan DM, Dalton WS.
    Int J Cancer; 1996 May 16; 66(4):520-5. PubMed ID: 8635868
    [Abstract] [Full Text] [Related]

  • 2. Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line.
    Abbaszadegan MR, Foley NE, Gleason-Guzman MC, Dalton WS.
    Int J Cancer; 1996 May 16; 66(4):506-14. PubMed ID: 8635866
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf JM, Levy SB.
    Cancer Res; 1994 Nov 01; 54(21):5607-13. PubMed ID: 7923205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.
    Ganapathi R, Grabowski D, Ford J, Heiss C, Kerrigan D, Pommier Y.
    Cancer Commun; 1989 Nov 01; 1(4):217-24. PubMed ID: 2576973
    [Abstract] [Full Text] [Related]

  • 11. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G.
    Mol Pharmacol; 1995 Jan 01; 47(1):51-6. PubMed ID: 7838133
    [Abstract] [Full Text] [Related]

  • 12. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
    Nakagawa M, Schneider E, Dixon KH, Horton J, Kelley K, Morrow C, Cowan KH.
    Cancer Res; 1992 Nov 15; 52(22):6175-81. PubMed ID: 1358431
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
    Slapak CA, Daniel JC, Levy SB.
    Cancer Res; 1990 Dec 15; 50(24):7895-901. PubMed ID: 1979251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.